Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.4 USD | -7.28% | -18.37% | -37.78% |
05-13 | Oppenheimer Adjusts Vor Biopharma Price Target to $10 From $15, Maintains Outperform Rating | MT |
05-09 | Vor Biopharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.78% | 103M | |
+48.69% | 58.71B | |
-2.82% | 41.31B | |
+36.42% | 39.2B | |
-11.22% | 27.4B | |
+9.60% | 26.55B | |
-22.60% | 18.98B | |
+1.89% | 12.51B | |
+26.48% | 12.08B | |
+21.82% | 11.94B |
- Stock Market
- Equities
- VOR Stock
- News Vor Biopharma Inc.
- Stifel Adjusts Vor Biopharma's Price Target to $21 from $24, Keeps Buy Rating